One of the most successful interventions in reducing infectious disease worldwide, vaccination still has limited effectiveness in protecting one group of patients—newborn infants. Now a study based at the Ragon Institute ...
Jun 13, 2019
0
121
A unique adjuvant, a substance that enhances the body's immune response to toxins and foreign matter, can prevent vaccine-enhanced respiratory disease, a sickness that has posed a major hurdle in vaccine development for respiratory ...
Jun 13, 2019
0
5
Antibodies are currently in use to treat diseases that range from cancer to autoimmunity and are usually administered to patients in multiple doses, much like medical drugs. However, the production and storage of antibodies ...
In healthy adults, RSV, or respiratory syncytial virus, feels like the common cold with a runny nose, chest congestion and cough. However, it is the second leading cause of death in infants. In fact, nearly 40 percent of ...
Mar 26, 2019
0
2
It's common knowledge that congested public places such as transit systems and airports harbor all kinds of potentially harmful microbes that pass easily from person to person. What's not clear is which infectious agents ...
Feb 20, 2019
0
3
Skin vaccination using a microneedle patch that contains the inactivated respiratory syncytial virus (RSV) and a compound that stimulates immune responses to the virus has been found to enhance protection against this serious ...
Dec 17, 2018
0
0
Pathologists at Houston Methodist developed a real-time website to track flu cases, just in time to assist physicians, the CDC and patients for the fall 2018 flu season.
Dec 06, 2018
0
0
As a leading global city with a high population density, Singapore is vulnerable to the introduction of biological threats. Initiating an early emergency response to such threats calls for the rapid identification of the ...
Dec 05, 2018
0
6
A team of scientists at Boston Children's Hospital has developed the first modeling system for testing age-specific human immune responses to vaccines—outside the body. The practical, cost-effective new platform, using ...
Nov 20, 2018
0
6
Almost every child gets respiratory syncytial virus (RSV), which causes cold-like symptoms. It's usually not a big deal if they're healthy, but every year in the U.S. some 57,000 children under the age of five are hospitalized ...
Nov 06, 2018
0
26
Human respiratory syncytial virus (RSV) causes respiratory tract infections. It is the major cause of lower respiratory tract infection and hospital visits during infancy and childhood. There is no vaccine, and the only treatment is oxygen.
In temperate climates there is an annual epidemic during the winter months. In tropical climates, infection is most common during the rainy season.
In the United States, 60% of infants are infected during their first RSV season, and nearly all children will have been infected with the virus by 2-3 years of age. Natural infection with RSV does not induce protective immunity, and thus people can be infected multiple times. Sometimes an infant can become symptomatically infected more than once even within a single RSV season. Severe RSV infections have increasingly been found among elderly patients.
RSV is a negative-sense, single-stranded RNA virus of the family Paramyxoviridae, which includes common respiratory viruses such as those causing measles and mumps. RSV is a member of the paramyxovirus subfamily Pneumovirinae. Its name comes from the fact that F proteins on the surface of the virus cause the cell membranes on nearby cells to merge, forming syncytia.
This text uses material from Wikipedia, licensed under CC BY-SA
